# The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR)

> **NCT01766505** · PHASE4 · TERMINATED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 32 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Candemore tablet
- **DRUG:** Cozzar tablet

## Key facts

- **NCT ID:** NCT01766505
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-06
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** lack of the subjects
- **Last updated:** 2014-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01766505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01766505, "The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01766505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*